|
|
 Purchase CD >>
Definition and Manipulation of the Hematopoietic Stem Cell Niche
Gregor Adams, Instructor, Massachusetts General Hospital
Multi-lineage Progenitor Cells (MLPC) an Umbilical Cord Blood-Derived Multi-potent Stem Cell that Arises from an Adherent CD45+/CD34+/CD9+ Subset
Dan Collins, CSO, BioE
Clinical Use of Adipose-Derived Stem Cells in Over 2,000 Orthopedic Cases in the Equine and Canine
Robert Harman, CEO, VetStem Inc.
A New Pluirpotent Human Stem Cell Platform Grown Directly on Plastic, Scalable for use in Many Different Drug Discovery Applications
James Kelly, CEO, Stem Cell Innovations
The Biopolitical and Therapeutic Landscape of Stem Cell Research
Stephen Minger, Director, Stem Cells Biology Laboratory, King’s College
Transplants of Human Embryonic Stem Cells (HESC) Improved Motor Function recovery in Spinal Cord Injured Rats
Jay Sharma, CEO and CSO, Celprogen
Innovations in Stem Cell Culture
Steven Sheridan, Group Leader, Millipore
Adult Neural Crest Stem Cells from Hair Follicles
Maya Sieber-Blum, Professor, Medical College of Wisconsin
Current Requirements for Manufacturing Stem Cells for Clinical Trials
Alan Smith, President and COO, Cognate Bioservices
Embryonic Stem Cells: Tools for Drug Discovery and Development
Ralph Snodgrass, CEO, VistaGen Therapeutics
|
|
|